Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 14

1.

High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo.

Faraco G, Fossati S, Bianchi ME, Patrone M, Pedrazzi M, Sparatore B, Moroni F, Chiarugi A.

J Neurochem. 2007 Oct;103(2):590-603. Epub 2007 Jul 31.

2.

The non-competitive metabotropic glutamate receptor-1 antagonist CPCCOEt inhibits the in vitro growth of human melanoma.

Haas HS, Pfragner R, Siegl V, Ingolic E, Heintz E, Schraml E, Schauenstein K.

Oncol Rep. 2007 Jun;17(6):1399-404.

PMID:
17487397
3.

The plasma membrane Na+/Ca2+ exchanger is cleaved by distinct protease families in neuronal cell death.

Bano D, Munarriz E, Chen HL, Ziviani E, Lippi G, Young KW, Nicotera P.

Ann N Y Acad Sci. 2007 Mar;1099:451-5.

PMID:
17446485
4.

Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration.

Emdad L, Sarkar D, Su ZZ, Lee SG, Kang DC, Bruce JN, Volsky DJ, Fisher PB.

Pharmacol Ther. 2007 May;114(2):155-70. Epub 2007 Feb 24. Review. Erratum in: Pharmacol Ther. 2007 Jul;115(1):176.

5.

Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.

Namkoong J, Shin SS, Lee HJ, Marín YE, Wall BA, Goydos JS, Chen S.

Cancer Res. 2007 Mar 1;67(5):2298-305.

6.

Hypothesis of the cause and development of neoplasms.

Hoang BX, Levine SA, Pham P, Shaw DG.

Eur J Cancer Prev. 2007 Feb;16(1):55-61.

PMID:
17220705
7.

Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers.

Ippolito JE, Merritt ME, Bäckhed F, Moulder KL, Mennerick S, Manchester JK, Gammon ST, Piwnica-Worms D, Gordon JI.

Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12505-10. Epub 2006 Aug 8.

8.

Aminothiols in human brain tumors.

Bicíková M, Kríz L, Mohapl M, Burkonová D, Tallová J, Husek P.

Clin Chem Lab Med. 2006;44(8):978-82.

PMID:
16879064
9.

The glutamatergic system outside the CNS and in cancer biology.

Kalariti N, Pissimissis N, Koutsilieris M.

Expert Opin Investig Drugs. 2005 Dec;14(12):1487-96. Review.

PMID:
16307489
10.

Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon.

Marín YE, Namkoong J, Cohen-Solal K, Shin SS, Martino JJ, Oka M, Chen S.

Cell Signal. 2006 Aug;18(8):1279-86. Epub 2005 Nov 21.

PMID:
16305822
11.

Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression.

Li S, Huang S, Peng SB.

Int J Oncol. 2005 Nov;27(5):1329-39. Review.

PMID:
16211229
12.

The expression of NMDA receptor 1 is associated with clinicopathological parameters and prognosis in the oral squamous cell carcinoma.

Choi SW, Park SY, Hong SP, Pai H, Choi JY, Kim SG.

J Oral Pathol Med. 2004 Oct;33(9):533-7.

PMID:
15357673
13.

Glutamate antagonists limit tumor growth.

Rzeski W, Ikonomidou C, Turski L.

Biochem Pharmacol. 2002 Oct 15;64(8):1195-200. Review.

PMID:
12234599
14.

Glutamate antagonists: deadly liaisons with cancer.

Cavalheiro EA, Olney JW.

Proc Natl Acad Sci U S A. 2001 May 22;98(11):5947-8. No abstract available.

Supplemental Content

Support Center